Table 2. Pooled hazard ratios for OS according to subgroup analyses.
Outcome subgroup | No. of patients | No. of studies | HR (95% CI) | P value | Model | heterogeneity | |
---|---|---|---|---|---|---|---|
I2 (%) | P | ||||||
Overall survival | 6278 | 25 | 2.13(1.69–2.69) | <0.001 | random | 88.7% | <0.001 |
Ethnicity | |||||||
Asian | 1206 | 6 | 2.22(1.27–3.87) | 0.005 | random | 86.4% | <0.001 |
Caucasian | 5072 | 19 | 2.06(1.73–2.44) | <0.001 | random | 54.3% | 0.003 |
Cut-off value | |||||||
1.5ULN | 4414 | 13 | 1.96(1.43–2.68) | <0.001 | random | 87.9% | <0.001 |
Others | 1864 | 12 | 2.21(1.73–2.83) | <0.001 | random | 59.4% | 0.004 |
Analysis type | |||||||
Multivariate | 5016 | 21 | 2.11(1.63–2.71) | <0.001 | random | 89% | <0.001 |
Univariate | 1262 | 4 | 1.98(1.52–2.56) | <0.001 | fixed | 43.3% | 0.152 |
Tumor type | |||||||
All stage | 1159 | 5 | 2.41(1.09–5.33) | 0.03 | random | 77.8% | 0.001 |
Metastasis | 4686 | 18 | 2.02(1.57–2.59) | <0.001 | random | 89.3% | <0.001 |
Non-metastasis | 433 | 2 | 3.67(1.33–10.13) | 0.012 | random | 52.8% | 0.146 |
Abbreviation: OS = overall survival; HR = hazard ratio; CI = confidence interval.